These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17206663)

  • 1. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.
    De la Morena F; Martín L; Gisbert JP; Fernández Herrera J; Goiriz R
    Inflamm Bowel Dis; 2007 Apr; 13(4):509-10. PubMed ID: 17206663
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
    Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
    Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.
    Teich N; Klugmann T
    J Crohns Colitis; 2014 Jan; 8(1):85-6. PubMed ID: 23810275
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
    Cocco A; Angelucci E; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
    [No Abstract]   [Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
    López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
    Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis.
    Botros N; Pickover L; Das KM
    Gastroenterology; 2000 Apr; 118(4):654, 809. PubMed ID: 10777349
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
    Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
    Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
    Nybaek H; Jemec GB
    Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].
    Krag AA; Gjersøe P
    Ugeskr Laeger; 2005 May; 167(18):1968-9. PubMed ID: 15929274
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab for treatment of pyoderma gangrenosum with ulcerative colitis.
    Joob B; Wiwanikit V
    J Crohns Colitis; 2013 May; 7(4):e153. PubMed ID: 22981616
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
    Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
    J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
    Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
    Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
    Baglieri F; Scuderi G
    Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
    Sinagra E; Orlando A; Renna S; Maida M; Cottone M
    Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis with refractory pyoderma gangrenosum.
    Liu FC; Liu NT; Huang TY
    QJM; 2020 Aug; 113(8):567-568. PubMed ID: 32129869
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.